Abciximab-induced alveolar hemorrhage after percutaneous coronary intervention

Abciximab, a platelet glycoprotein (GP) IIb/IIIa inhibitor, has been shown to improve clinical outcomes in patients undergoing percutaneous coronary intervention. However, there is a well-documented increase in bleeding risk associated with the use of this agent. Spontaneous pulmonary hemorrhage is...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Conley, Maria, Patino, Gilberto, Romick, Benjamin, Almaleh, Michael, Campbell, Charles, Hawkins, Karin, Moore, Scott, Allan, Patrick
Natura: Artigo
Lingua:Inglês
Pubblicazione: Pulsus Group Inc 2008
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2644574/
https://ncbi.nlm.nih.gov/pubmed/18273491
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi